Lucentis medication delivered to the Perinatology Center in Almaty to save the vision of 5 premature newborns!

Every year about 22 thousand premature babies are born in Kazakhstan, more than two thousand children have eye disease, which can lead to loss of eyesight. Aggressive retinopathy of prematurity is a rapidly progressive, malignant form of eye disease, which is characterized by a lightning course and rapid development of retinal detachment in newborns. Taking into account the area of the lesion in aggressive retinopathy of prematurity, the lightning speed of the pathological process development can be from 24 to 72 hours. The Perinatal Center of Almaty has the most experienced neonatal ophthalmologist in the country, who has been successfully performing surgeries on babies for 11 years. This disease is treated by laser coagulation of the retina. According to the world standards, before the operation it is necessary to apply intravitreal injection of angiogenesis inhibitors. Currently, the drug preparation Lucentis (active substance - ranibizumab) is authorized for use as a treatment in Kazakhstan. The price of 1 ampoule is 177,200 tenge. Since there is very little time between diagnosis and the need for treatment, Lucentis should always be available at the Center. Many parents do not have the financial ability to purchase the drug preparation on their own. Your support will help the doctors to save eyesight of 5 little children and will have a significant impact on the well-being of these little patients.